Back to top
more

Arcadia Biosciences (RKDA)

(Real Time Quote from BATS)

$4.60 USD

4.60
1,708

0.00 (0.00%)

Updated Aug 7, 2025 02:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (100 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Madhurima Das headshot

3 Stocks to Watch in the Thriving Agriculture - Products Industry

by Madhurima Das

The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 46.34% and 2.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Orion (OEC) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Orion (OEC) delivered earnings and revenue surprises of -10.17% and 16.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GrowGeneration (GRWG) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

GrowGeneration (GRWG) delivered earnings and revenue surprises of -28.57% and 0.15%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Sanghamitra Saha headshot

5 Stocks With Rising P/E to Bet on for Solid Gains

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).

Zacks Equity Research

Westlake Chemical (WLK) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Westlake (WLK) delivered earnings and revenue surprises of -18.37% and 5.73%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Intrepid Potash (IPI) Q2 Earnings Lag Estimates

by Zacks Equity Research

Intrepid Potash (IPI) delivered earnings and revenue surprises of -26.67% and 21.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

The Andersons (ANDE) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Andersons (ANDE) delivered earnings and revenue surprises of 43.40% and 3.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Madhurima Das headshot

4 Agriculture - Products Stocks to Watch in a Challenging Industry

by Madhurima Das

Despite the Agriculture - Products industry facing elevated input costs and supply chain issues, stocks like Bunge (BG), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA) are poised well to withstand the same.

Zacks Equity Research

Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia Biosciences

by Zacks Equity Research

Bunge, CalMaine Foods and Arcadia Biosciences are part of the Zacks Industry Outlook article.

Madhurima Das headshot

3 Stocks to Watch in the Promising Agriculture - Products Industry

by Madhurima Das

The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Madhurima Das headshot

3 Stocks Worth a Look in the Thriving Agriculture - Products Industry

by Madhurima Das

With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Hecla Mining (HL) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Hecla Mining (HL) delivered earnings and revenue surprises of 50% and 12.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

GrowGeneration (GRWG) delivered earnings and revenue surprises of 0% and 23.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

The Andersons (ANDE) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Andersons (ANDE) delivered earnings and revenue surprises of 51.52% and 34.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Bunge (BG) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Bunge (BG) delivered earnings and revenue surprises of 41.39% and 7.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Buy Stocks for October 24th

by Zacks Equity Research

BXRX, WOLF, GHRS, RKDA and BHR have been added to the Zacks Rank #1 (Strong Buy) List on October 24, 2022.

Madhurima Das headshot

3 Stocks to Watch in the Promising Agriculture - Products Industry

by Madhurima Das

With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

by Zacks Equity Research

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

by Zacks Equity Research

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sanghamitra Saha headshot

Why Marijuana ETFs & Stocks Have More Room to Run

by Sanghamitra Saha

Marijuana stocks and ETFs are hot this year and can perform better in the coming days.

Sanghamitra Saha headshot

Why These Pharma ETFs Rallied on Thursday

by Sanghamitra Saha

A few pharma ETFs hit a one-month high on Feb 28. Why?

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 59.29% and 42.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?